We’re the leading resource for those affected by bleeding disorders. You can count on our organization to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.
Pfizer and Sangamo presented their gene therapy updates in a poster presentation during the 61st Annual Meeting of the American Society of Hematology in Orlando, Florida.
These educational activities are designed specifically for healthcare providers who may be new to this field or who function outside the hemophilia treatment center network, including primary care physicians, obstetrician/gynecologists, nurse/nurse practitioners, dentists, oral surgeons and other allied professionals.
This document provides critical guidance for when emergency department personnel encounter a patient with hemophilia or other bleeding disorder.
HFA and NHF have responded to our community’s needs and assembled a Safety Summit to be held in January of 2020.
The therapy is for patients with severe and moderately severe hemophilia B.
Subscribe to Our Newsletter
Fill in the fields below to receive our email newsletter.